SCHEMBL20802973

SCHEMBL20802973

N#Cc1ccc(-c2ccc3cc(-c4ccc5c6c(-c7ccccc7)c7c(cc8c9ccccc9c9cccc7c98)c(-c7ccccc7)c6c6cccc4c65)ccc3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ HRH3 Q9Y5N1 5/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B1 P14061 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20802905 1.00 CYP17A1 (0.35) CYP17A1CYP11B1CYP11B2HRH3ESR1
SCHEMBL20803114 1.00 CYP17A1 (0.35) CYP17A1CYP11B1CYP11B2HRH3ESR1
SCHEMBL25005767 0.94 CYP11B1 (0.38) CYP17A1CYP11B1CYP11B2ALDH1A1ATM
SCHEMBL22916738 0.94 CYP11B1 (0.38) CYP17A1CYP11B1CYP11B2ALDH1A1ATM
SCHEMBL14139970 0.94 PRKDC (0.35) ALDH1A1ATMGABRA1GABRG2GABRB3
SCHEMBL14139961 0.94 PRKDC (0.35) ALDH1A1ATMGABRA1GABRG2GABRB3
SCHEMBL23349018 0.93 KDM1A (0.37) CYP17A1CYP11B1CYP11B2KDM1ASLC22A12
SCHEMBL23349048 0.93 KDM1A (0.37) CYP17A1CYP11B1CYP11B2KDM1ASLC22A12
SCHEMBL14139947 0.91 ALDH1A1 (0.38) ALDH1A1ATMGABRA1GABRG2GABRB3
SCHEMBL14139948 0.91 ALDH1A1 (0.38) ALDH1A1ATMGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345816-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-26 — — US disclosed
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-08-03 — — US disclosed
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-08-03 — — US disclosed
US-20230047477-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 — — US disclosed
US-20230042023-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-09 — — US disclosed
US-11552252-B1 — — 2023-01-10 — — US disclosed
EP-3422431-B1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO (JP) 2021-11-03 — — EP disclosed
WO-2021107030-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-06-03 — — WO disclosed
US-20190245152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-08-08 — — US disclosed
US-20190081249-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD (JP) 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EP300, RPS19, RER1 CYP17A1 3314/4885CYP11B1 3341/4885CYP11B2 3406/4885
US-20230345816-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, YBX1 CYP17A1 1139/4885CYP11B1 1494/4885CYP11B2 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback